The AE protocol is designed to test a subject's intrinsic ability to attain and maintain a stable dynamic of oscillatory autoregulatory RR-interval (RRI) and arterial blood pressure (BP) control. AE Guest editor for this article was Douglas P. Zipes, MD. The online-only Data Supplement is available at http://circep.ahajournals.org/lookup/suppl/Background-Risk assessment studies use a suite of nominally independent noninvasive heart rate metrics, often brought together in a statistical model to compute a risk score. The ongoing need to noninvasively identify the higher risk patients requiring more invasive investigations/interventions drives the search for better noninvasive predictive metrics, with increased sensitivity. Many varieties of autoregulatory malfunction occur within the cardiovascular system; thus, it seems a daunting challenge to build predictive models that account for all potential modes of failure. Auto-entrainment (AE) methodology was developed to help address this challenge. Methods and Results-AE methodology tests intrinsic capacity to maintain a stable and coherent oscillatory dynamic of autoregulatory control via respiratory entrainment of the blood pressure and heart period. Using cardiovascular death (n=18) at follow-up (1.5 years) as the end point, analysis of AE measurements from 148 patients with heart failure revealed 2 parameters significantly predictive of death. Using logistic regression, the magnitude of systolic pulsus alternans measured during AE had predictive sensitivity of 90% (confidence interval, 62%-100% and specificity of 62% (confidence interval, 49%-74%). The capacity to maintain a stable oscillatory dynamic was measured by the fraction of the total RR-interval spectral power contained within the AE-band. This capacity had predictive sensitivity of 73% (confidence interval, 47%-99%) and specificity of 55% (confidence interval, 43%-66%).
N ominally independent noninvasive cardiovascular risk metrics are often brought together to compute a single cardiovascular risk score. This approach is generally successful, yet there is an ongoing need to refine noninvasive metrics to produce better predictive models; particularly models with increased predictive sensitivity. Poor sensitivity of noninvasive risk scores limits their pragmatic utility to identify higher risk patients who require more invasive investigations and interventions.
Clinical Perspective on p 136
Both baroreflex sensitivity and respiratory sinus arrhythmia (RSA) may be considered nominally independent measures of capacity for heart rate (HR) change. Studies indicate that diminished capacity for HR change reduces baroreflex sensitivity and RSA scores; low scores are often prognostic of a poor outcome. [1] [2] [3] [4] These 2 tests share common limitations: (1) the measure obtained for each can be confounded by other normal physiological mechanisms 5 and (2) the lowest score that can be obtained is zero; representing the complete inability to make normal functional HR change in response to normal physiological challenges. Is this really the worst (riskiest) state? Possibly not; what about risk attributable to intermittent malfunctions, such as arrhythmias and alternans? These intermittent malfunctions differ qualitatively from the aforementioned failure in that they represent a response that is outside the boundaries of normal systemic responses. In other words, these intermittent nonsystematic malfunctions represent different dimensions of failure. The need to account for a plethora of potential intermittent systemic malfunctions provides the motivation to consider a different strategy for noninvasive risk assessment.
In this study, we attempt to address this challenge by introducing auto-entrainment (AE): a new noninvasive technology that provides the physiological and numeric basis for quantifying the autoregulatory control capacity of the integrated cardiovascular and cardiorespiratory control systems. The purpose of this study was to investigate the prognostic value of AE in hospitalized patients with heart failure (HF). uses audiovisual prompts gated to the R-wave of the ECG to guide voluntary respiration. AE is similar to paced (or metronomic) breathing in that (1) the subject is always aware of their current position within the respiratory cycle and (2) the subject is guided as to when to switch from inspiration and expiration. The difference between AE and metronomic breathing is that metronomic breathing uses an external reference clock to set the timing of the respiratory cycle, whereas AE uses the intrinsic cardiac rhythm as the reference clock. Obviously, the external reference clock used for metronomic breathing produces near perfect cyclic timing regardless of the functional status of autoregulatory control processes. However, because AE uses the intrinsic cardiac cycle as the reference clock, this demands that all cyclic autoregulatory control processes (eg, respiration, RSA, baroreflex, BP control) must function in a coherent manner so as to yield a stable (ie, with respect to magnitude, period, and phase) oscillatory dynamic. A block diagram of the ProDAQ acquisition device and brief video of AE data acquisition can be viewed in the online-only Data Supplement. Figure 1 shows typical RRI and BP sequences recorded from the AE protocol. Seated subjects initially performed spontaneous respiration for 60 seconds, followed by 60 seconds of AE, finishing with 2 full cadence cycles of respiratory pause. The scripted respiratory pause begins on the second beat of inspiration, with the lungs only partially inflated to minimize the chance of Valsalva. Figure 1 also shows that under spontaneous respiratory conditions it is difficult to visually relate individual transients of RRI and BP to specific autoregulatory processes (eg, RSA, baroreflex, etc.). However, after 30 seconds of AE, this temporal uncertainty of process resolves; the subject attains and maintains a coherent stable oscillatory dynamic of coupled respiration, BP, and RRI. To assess whether this oscillatory dynamic was exclusively RSA in origin, a respiratory pause was scripted into the protocol. Figure 1 clearly demonstrates that at the onset of the respiratory pause, the BP and RRI signals continue their rhythmic cycling in an uninterrupted manner. Furthermore, throughout the pause (ie, in the absence of a respiratory forcing function), both the RRI and the BP sequences continue a low-frequency phase-locked oscillation. Thus, these respiratory pause sequences do indeed indicate an active role for the baroreflex during AE. Figure 1 also shows that the peak-to-peak magnitude of the RRI oscillations decreases during the respiratory pause (relative to AE). Of course, there is no direct RSA component during the respiratory pause; thus, this diminished magnitude originates from baroreflex only. Figure 2 shows the spectral analysis of RRI and BP sequences from Figure 1 . Note that the BP and RRI sequences show peak spectral power and coherence within the AE-band.
Analyses
Both spectral and time-domain analyses were performed. A complete description of the analytic and statistical methods is presented in the Methods in the online-only Data Supplement. This is a single center study.
Prospective Study
The design of the prospective clinical investigation is schematically illustrated in Figure 3 . The Ethics Review Board approved the protocol as a pilot study for new technology development. Figure 1 . Beat-to-beat sequences of RR-interval (RRI) and blood pressure recorded from hiker subject undergoing the auto-entrainment (AE) protocol. Note the transition from spontaneous respiration to AE. Note the state of high signal coherence and oscillatory stability achieved in the 30 seconds window before respiratory pause. Note further that the oscillatory behavior continues during respiratory pause indicating ongoing baroreflex activity in the absence of a respiratory forcing function.
Spontaneous Respiration

Auto-Entrainment
Study Population: Heart Failure
Patients were considered eligible for the study if their hospital admission diagnosis was HF and their echocardiograms, cardiac magnetic resonance imaging, or heart catheterization documented left-ventricular dysfunction. The echocardiographic laboratory at the Foothills Hospital does not quantitatively estimate ejection fraction; instead left-ventricular systolic dysfunction is qualitatively described as mild, moderate, or severe. Adequacy of endocardial definition frequently precluded quantitative analysis. All patients on the cardiology ward were screened on a given day for the admission diagnosis of HF. A cardiologist (H.D.) then reviewed each patient to establish the existence of structural heart disease. All such patients on the hospital ward were considered candidates. If the patients were available (not undergoing clinical tests), then they were approached for consent. Consenting patients were consecutive except if: (1) atrial fibrillation and a paced rhythm was manifest or (2) patients were called away from the ward for clinically necessary test. In patients who had heart catheterizations within the hospitalization, left-ventricular end diastolic pressure data were assessed. Elevated end diastolic pressure was arbitrarily defined as >20 mm Hg. Left-ventricular hypertrophy was defined as septal or posterior wall thickness >11 mm. Ventricular tachycardia was defined as >5 consecutive beats during protracted monitoring in hospital or at Holter monitoring. Implantable cardioverter-defibrillators were implanted as per the cardiologists' Figure 1 . A, Power spectral density plots of BP (grey lines, solid, dotted, and dashed) and RRI (black line). Note that almost all spectral power for each signal is contained within the auto-entrainment (AE) band (grey rectangle). B, Plot of spectral coherence between RRI and each of the BP sequences. Note that spectral coherence is maximal within the AE-band. 
Discovery
Discovery Phase
The purpose of the discovery phase was to use a small subset (n=50 survivors; n=5 deceased) of the patient population to determine which metrics from the AE protocol had putative prognostic value ( Figure 3 ). These patients were randomly selected after all data were collected. The Matlab random number generator (rand) was used to randomly select the discovery phase patients. The Mann-Whitney U test was performed and measurements were considered as putatively prognostic for P<0.05.
Validation Phase
The metrics that proved putatively significant (P<0.05) in the discovery phase were then validated using the remainder of the patient population (n=80 survivors; n=13 deceased). The Mann-Whitney U test was again performed and measurements were considered prognostic for P<0.05.
Model Phase
Those metrics which proved to be significantly prognostic at the validation phase were compiled for all (n=148) subjects with HF. These features and clinical data were combined in multiple logistic regression models. Receiver-operator characteristics were determined. The end point of this study was total cardiovascular mortality.
Results
Auto-Entrainment Percentage
The AE-band percentage of the total RRI spectral power obtained during AE is referred to as AE%. Figure 4A 
Auto-Entrainment
A PVC premature ventricular contraction Figure 4 . A, RR-interval (RRI) and pulse pressure sequences obtained for a patient with heart failure undergoing auto-entrainment (AE) protocol. Note that the pulse pressure sequence shows a well-defined 9-beat cyclicity corresponding to the In4:Out5 cadence used during AE. Note that a single premature ventricular contraction (PVC) occurred during AE. This was immediately followed by large magnitude pulsus alternans, which progressively diminished in magnitude and disappeared after 5 beats, whereupon regular blood pressure cyclicity was resumed. B, Note the well-defined AE-band spectral peak for pulse pressure (closed circle), and conspicuous absence of RRI spectral power (open circle) within the AE-band. Most of the RRI spectral power is distributed over a wide frequency band ranging from ≈0.3 to ≈0.8 Hz. Some of this high frequency power originates in the RRI alternans that occur intermittently throughout the AE sequence. The AE% is very low indeed, associated with a poor prognosis for the patient. C, Histograms for AE% obtained during the validation phase;
Mann-Whitney U test indicates a significant difference between patients with HF alive at follow-up vs deceased at follow-up. D, Kaplan-Meier survival functions estimated for AE%; dichotomized using the median AE%.
magnitude and resolved after 5 sinus beats, whereupon the regular BP cyclic was resumed. The normalized power spectrum corresponding to this BP sequence is shown in Figure  4B . Note that peak BP spectral power occurs within the dominant AE-band. The remaining spectral power is distributed across the spectrum and diminishes with increasing frequency. AE% was associated with death. Figure 4C shows histograms for AE% obtained during the validation phase. The deceased at follow-up cohort manifest significantly reduced AE% compared with the alive at follow-up group (P=0.013, Mann-Whitney U test). The normalized RRI power spectrum of the corresponding sequence is also shown in Figure 4B . Note the conspicuous absence of RRI spectral power within the AE-band. Instead, most of the RRI spectral power is distributed over a wide frequency band ranging from ≈0.3 to ≈0.8 Hz. Some of this high frequency power originates in the RRI alternans which occur intermittently throughout the AE sequence. Thus, it is clear that for this example AE% is very low indeed, associated with a poor prognosis for the subject who died in follow-up. The estimated Kaplan-Meier survival curves dichotomized at median AE% are presented in Figure   4D . The curves were significantly different with log-rank P=0.05. Figure 5A illustrates RRI and pulsus alternans as they occur during AE. Note that for this subject the pulsus alternans are ubiquitous, whereas the RRI alternans are intermittent. Figure 5C shows alternans signal averages of the ECG and BP traces using the R-wave as the fiduciary point. In this instance, the signal average ECG and BP traces from the pulsus alternans maxima beats (solid line) are compared with those from the pulsus alternans minima beats (dashed line). Note the distinct pulsus alternans with the apparent lack of coincidental alternans morphology expressed in the ECG signals. This clear pulsus alternans expression in the absence of a clear ECG morphology alternans expression was typical for those subjects who produced large magnitude pulsus alternans. The magnitude of systolic pulsus alternans occurring during AE was also associated with death. Figure 5B shows histograms for pulsus alternans magnitudes obtained during the validation phase. The dead at follow-up cohort was significantly increased in pulsus alternans magnitude compared with the alive at follow-up cohort (P=0.019, Mann-Whitney U test). The estimated Kaplan-Meier survival curves dichotomized at median systolic pulsus alternans magnitude are presented in Figure 5D . The survival curves were significantly different with logrank P=0.02. Figure 6 shows another subject with large magnitude pulsus alternans and an apparent lack of ECG morphology alternans. In this example, the pulsus alternans magnitude is augmented by the occurrence of PVCs; after the PVCs, this magnitude is seen to decay slowly as a function of time. This is consistent with previous reports 6 of PVC augmentation of pulsus alternans magnitude. Table 1 lists the clinical parameters obtained for each subject. Using all study patients (n=148), each of these parameters was tested in a model of univariate and multivariate logistic regression. Receiver-operator characteristics curves were generated for each univariate logistic regression. Table 2 shows the single clinical parameter with significant area under the curve. Previous hospitalization for heart failure had an area under the curve=0.63 (P<0.03). In a similar manner, Table 2 presents results from logistic regression models using AE% and pulsus alternans magnitude. The receiver-operator characteristics curves for univariate logistic regression of pulsus alternans magnitude and AE% yielded areas under the curve of 0.78 and 0.68, respectively (P<0.01 and 0.03, respectively). Combined in a multivariate logistic regression, the receiver-operator characteristics curve for pulsus alternans magnitude+AE% yielded an area under the curve of 0.78 (P<0.01). The sensitivity of systolic pulsus alternans magnitude was 90%, with a specificity of 62% and a positive predictive accuracy of 28%. In contrast, the sensitivity of AE% is 73% with a positive predictive accuracy of 19%. When considering both physiological metrics in concert, the receiver-operator characteristics curves did not show improvement. Consideration of previous hospitalization and pulsus alternans magnitude modestly improved the positive predictive accuracy, from 28% to 37%, but this was not statistically significant. The negative predictive value of most tests is high (>90%). Even the clinical parameter of previous hospitalizations for HF had a strong negative predictive value of 91%.
Pulsus Alternans Magnitude
Logistic Regression Models
To assess the potential added value of information provided by adding information about previous hospitalization for HF and AE% to the results of BP alternans, net reclassification improvement (NRI) tests were performed. To calculate the NRI results, the results of previous hospitalization were added to results of systolic pulsus alternans; the NRI was −0.38, P<0.01. That is, addition of this information to systolic pulsus alternans made prediction worse. When the results of AE% were added to systolic pulsus alternans, the NRI was −0.45, P<0.005. That is, addition of the AE% information worsened prediction. When information on previous hospitalization was added to AE%, the NRI is −0.3, P<0.05.
That is, addition of information about previous hospitalization to information provided by AE worsened overall prediction. These data suggest that the best single test is systolic pulsus alternans recorded during AE and adding other information did not improve prediction.
Discussion
In this study, the AE protocol was used to provide a noninvasive platform for acquiring physiological data under tightly constrained dynamic physiological conditions. Unlike independent tests for baroreflex sensitivity and RSA, which can be confounded by unaccounted-for mechanical/neurological coupling, the AE protocol is more a measure of the stability of the coupling itself. The cyclic nature of the AE protocol is also naturally amenable to spectral analysis. Moreover, the resulting frequency domain provides a natural basis for computing scores required for prognostic assessment. For example, if all RRI spectral power is contained within the AE-band, then the subject has the maximum systematic coupling capacity to attain a stable cyclic dynamic. Alternatively, if all RRI spectral power occurs outside of the AE-band, then this represents the minimum coupling capacity. More importantly, AE% weighs functional HR change against malfunction HR change. Any failure in sensing, coupling, or response during AE results in RRI spectral power outside of the AE-band and a reduction in AE% score. Thus, the AE% metric is sensitive to a wide variety of dynamic and intermittent cardiovascular system failures.
Pulsus alternans are clearly an expression of the system's malfunction susceptibility. Pulsus alternans were most often observed as intermittent malfunctions. Because of this intermittency, pulsus alternans magnitude could not be accurately assessed using spectral methods; thus, we used time-domain calculations. Some patients displayed pulsus alternans generation and magnitude augmentation in response to PVCs. Thus, in these instances, BP malfunction is strongly coupled to a cardiac rhythm malfunction. In our analysis, BP values from PVCs and compensatory pause beats were excluded from the magnitude measurements. Nevertheless, as seen in Figure 6 , the effects of the PVCs on pulsus alternans magnitude often extend many beats beyond the PVC itself. Thus, for some patients, the measured magnitude of the pulsus alternans malfunction is dependent on the system's cardiac rhythm malfunction susceptibility. Thus, it is not surprising that the magnitude of the pulsus alternans as measured during the AE protocol is the most sensitive predictor of death. The AE protocol provided the well-constrained numeric basis for accurate estimate of pulsus alternans (not confounded by irregular respiration and BP changes), and the magnitude of the pulsus alternans represents an integration of both cardiac rhythm malfunction and BP malfunction.
The pulsus alternans example also illustrates that measures of cascading malfunction (where one systematic malfunction modulates another systematic malfunction in frequency and magnitude) may be the most sensitive prognostic indicators of death. In this sense, it is not surprising that RRI functional capacity metrics, such as standard deviation of the average normal-to-normal RRI (SDANN), ultra-low frequency (ULF), low frequency (LF), high frequency (HF), percent of normal-to-normal adjacent RRI whose difference exceeds 50 msec (PNN50), and all other RRI metrics that explicitly exclude systemic malfunction, have poor predictive sensitivity. Accordingly, it is also not surprising that metrics, such as HR turbulence (HRT), which do incorporate systematic malfunctions, are more sensitive prognostic indicators of death. Moreover, as we have demonstrated previously, [7] [8] [9] the HRT phenomenon is tightly coupled to BP changes evoked by the early beats. Thus, the HRT metric actually incorporates another coupled dimension of systematic response (ie, BP). In the present study, HRT could not be properly evaluated because of the short length of the recordings and the general paucity of early beats in the short recordings. Interestingly, HRT was observed in one of the patients during the quiet seated rest period, but PVCs during AE did not result in an HRT-type response (ie, brief tachycardia followed by slow onset bradycardia).
Finally, neither the number nor the magnitude of T-wave alternans (TWA) was a significant predictor of death. As with HRT, it is possible that the AE protocol was not conducive to expression of TWA. Consider again Figure 5 , and note that in the presence of large magnitude pulsus alternans the ECG showed no indications of TWA. This lack of TWA during pronounced pulsus alternans was observed for several patients exhibiting pulsus alternans. Given that TWA is a known predictor of cardiac death, and that the protocols presented here failed to manifest TWA, it is reasonable to conjecture that TWA and pulsus alternans may manifest under different physiological conditions. As such, each may represent a unique (and apparently incompletely coupled) malfunction of the cardiovascular control system.
Limitations
This study provides new metrics that have relatively high sensitivity to predict death. However, in this cohort of patients, we did not simultaneously measure TWA with the standard algorithm, nor did our protocol include prolonged ECG acquisition necessary for HRT analysis. Another limitation is that measurements of nonspontaneous measurements of baroreflex sensitivity by infusion of phenylephrine and nitroprusside or neck suction were not examined in this study. Our ability to discriminate the cause of death was limited by the information available by telephone interview of family members. Family members were sometime unwilling or unable to provide precise details. Telephone calls frequently This study was approved by our Human Ethics Committee as a pilot trial. After the second year renewal, the committee reviewed our progress and indicated that because this was a pilot study, we had been given sufficient numbers of patients to perform a pilot. Accordingly, the study was terminated. There had originally been no formal a priori calculation of sample size. The results of this pilot study need to be replicated in a separate population.
Conclusion
Using the AE protocol, increased predictive sensitivity for cardiac risk assessment is achieved. The context of this protocol allows measurement of the integrated coupling function of the cardiovascular system to the challenge of attaining coherent autoentrained respiration, baroreflex, RRI, and BP measurements.
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CLINICAL PERSPECTIVE
Identification of patients with heart failure at high risk remains challenging. Diminished baroreflex sensitivity and heart rate variability are associated with mortality, but measurement can be confounded by other physiological mechanisms, and intermittent perturbations, such as those attributable to ambient ectopic activity. Auto-entrainment methods reflect the intrinsic capacity of autoregulatory control of heart rate and blood pressure to maintain a stable oscillatory dynamic during controlled breathing. In this exploratory study, the association of auto-entrainment measures to mortality was assessed in patients with heart failure. The magnitude of pulsus alternans during auto-entrainment and the RR-interval spectral power contained within the auto-entrainment frequency band were associated with mortality. Auto-entrainment methods warrant further assessment as predictors of mortality in heart failure.
